Position in IMCR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,476,204
+$506,685 QoQ
Shares Held
48,962
+75.3% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Persistent Asset Partners Ltd holds $59,316,956 across 109 Biotechnology names. IMCR ranks #12 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
133,066 | $4,329,967 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
92,516 | $3,560,940 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
15,905 | $3,006,840 | |
| 4 | ABVX |
Abivax S.A.
|
22,838 | $2,543,011 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26,043 | $2,532,681 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
45,953 | $2,422,642 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
37,472 | $2,116,793 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
51,336 | $1,956,928 |
All Filings in IMCR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,476,204 | 48,962 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $969,519 | 27,932 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,039,582 | 28,615 | Shares | Sole | 2026-01-15 | |
| 2025-06-30 | $754,312 | 24,038 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $662,531 | 22,330 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||